Is valproic acid oral solution approved for both monotherapy and adjunctive therapy?
Valproic acid oral solution is approved for use as monotherapy and adjunctive therapy in patients with complex partial seizures. This medication is also approved for simple and complex absence seizures and for patients with multiple seizure types that include absence seizures 1.
What the research says
The FDA approved valproic acid oral solution specifically for monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures 1. These seizures can occur either in isolation or in association with other types of seizures 3. The approval also covers use as sole and adjunctive therapy for simple and complex absence seizures 2. Additionally, it is indicated for adjunctive therapy in patients with multiple seizure types that include absence seizures 4.
What to ask your doctor
- Is valproic acid oral solution the right choice for my specific type of complex partial seizures?
- Should I use this medication as monotherapy or as an add-on to my current treatment plan?
- Are there any specific risks or side effects I should monitor while taking this oral solution?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.